SpacePharma says its miniature lab is a new way for researchers to work in microgravity for extended periods. Founder Yossi Yamin, “We upload the link with the command files to the lab and the experiment takes place.”
Reuters and Israel Hayom Staff
Orbiting the earth at more than 500 kilometers (300 miles), a tiny satellite with a laboratory the size of a tissue box is helping scientists carry out experiments that take gravity out of the equation.
Launch of the Indian Space Research Organization’s PSLV-C37 rocket, which carried SpacePharma’s DIDO nanosatellite – SpacePharma website
The technology was launched into space last month by SpacePharma, a Swiss-Israeli company. On Thursday, it announced that its first experiments have been completed successfully.
In space, with hardly any interference from Earth’s gravity, cells and molecules behave differently, helping researchers make discoveries in fields from medicine to agriculture. Nestle turned to zero gravity — or what scientists refer to as microgravity — to perfect the foam in its chocolate mousse and coffee, while drugmakers such as Eli Lilly have used it to improve drug designs.
Usually experiments are sent up to the International Space Station and carried out with the help of astronauts, or they are conducted on parabolic airplane flights that enjoy short bursts of weightlessness.
SpacePharma says its miniature lab is a new way for researchers to work in microgravity for extended periods.
“Everything can be done remotely while the system is in outer space,” said founder Yossi Yamin. “We upload the link with the command files to the lab and the experiment takes place.”
Clients then receive data and images directly from the experiments, which are carried out on custom-built glass chips and can be run multiple times to test different reactions.
DIDO, the SpacePharma System Satellite – SpacePharma website
The satellite holds four experiments, the first being done for a German research institute.
A second launch, also with four experiments, is scheduled for August and includes research for a leading pharmaceutical company, Yamin said.
By next year, he hopes to begin sending up satellites that each hold some 160 experiments.
View original Israel Hayom publication at:
Click, to Visit SpacePharma website to learn more.